Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-06-25

Clinical Trial Update: Nebivolol and Endothelial Regulation of Fibrinolysis (NERF) [Phase 4]

View source ↗

Summary

Phase 4 trial update for Nebivolol focusing on endothelial regulation of fibrinolysis; study completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nebivolol (Nebivolol)

Snippet

Sponsor: University of Colorado, Boulder | Conditions: Prehypertension, Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2019-06-25